基于CRISPR的快速分子诊断测试用于融合驱动的白血病
Rahul S Vedula1, Hannah Q Karp1, Jeremy Koob2
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Blood
|July 8, 2024
概括
新的基于CRISPR的SHERLOCK诊断试验可以准确地检测由融合驱动的白血病. 这项技术提高了及时诊断和有针对性的治疗选择的可访问性,改善了在各种医疗机构的患者结果.
科学领域:
- 分子诊断学 分子诊断学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 融合瘤基因对于癌症诊断和治疗选择至关重要.
- 目前用于融合驱动白血病的分子诊断方法并没有得到广泛的应用,这阻碍了及时治疗,特别是在社区医院和资源较低的地区.
研究的目的:
- 开发和验证基于CRISPR的RNA融合转录检测试验,用于诊断由融合驱动的白血病.
- 在专业实验室之外实现快速,可访问的分子诊断.
主要方法:
- 开发基于CRISPR的RNA融合转录检测试验,使用SHERLOCK (特定高灵敏度酶体记者解锁).
- 使用来自APL和CML病例的患者样本以及来自低资源环境的干血斑点的测定方法的验证.
主要成果:
- 开发的SHERLOCK试验在诊断APL和CML时显示出100%的灵敏度和特异性.
- 确定了测试优化,以促进在非三级癌症中心和临床实验室的使用.
结论:
- 基于CRISPR的SHERLOCK测定为诊断融合驱动型白血病提供了一种敏感和特定的方法.
- 这些快速的临床诊断可以通过扩大获得及时诊断和向治疗的机会,显著改善患者的治疗结果.
更多相关视频
相关概念视频
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...


